• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Expert Discusses Key Developments in Breath Biopsy

Expert Discusses Key Developments in Breath Biopsy

by Rachel Muenz | Aug 24, 2023 | News, Open Content

Owlstone Medical CEO discusses recent trends, the advantages of breath testing, and the challenges that must be met for wider clinical use.

Expert Q&A: The Latest in Breath Biopsy

Expert Q&A: The Latest in Breath Biopsy

by Rachel Muenz | Aug 23, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Special Focus-dtet

Owlstone Medical CEO Billy Boyle discusses the latest developments in breath biopsy and issues related to its wider clinical adoption.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Congress Moves to Permanently Restore Medicare Coverage of Pharmacy Lab Tests

Congress Moves to Permanently Restore Medicare Coverage of Pharmacy Lab Tests

by Glenn S. Demby | Jun 28, 2023 | Essential, Legislation-nir, National Lab Reporter

Congress is renewing its previous efforts to make Medicare reimbursement of pharmacy testing permanent—here’s what that could mean for labs.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
New Device Predicts the Efficacy of Hypnosis Treatment for Pain

New Device Predicts the Efficacy of Hypnosis Treatment for Pain

by Zahraa Chorghay, PhD | Apr 20, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet

The inexpensive POC device is a biosensor that performs COMT genotyping as a biomarker for hypnotizability.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Developing an Automated HIV Self-Test for Use in Developing Countries

Developing an Automated HIV Self-Test for Use in Developing Countries

by Holden Galusha | Feb 22, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Special Focus-dtet

Principal investigator discusses a new research initiative to create a low-cost, rapid HIV self-test.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com